LUNG vs FHTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

LUNG

32.6
AI Score
VS
FHTX Wins

FHTX

42.9
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
SELL

FHTX

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LUNG FHTX Winner
Revenue 66.18M 102.88M FHTX
Net Income -32.13M 31.08M FHTX
Net Margin -48.5% 30.2% FHTX
Operating Income -29.50M 26.26M FHTX
ROE -93.9% -220.7% LUNG
ROA -29.2% 16.3% FHTX
Total Assets 110.21M 190.95M FHTX
Cash 52.69M 80.30M FHTX
Current Ratio 4.05 4.24 FHTX
Free Cash Flow -18.51M -61.41M LUNG

Relative Price Performance (Last 90 Days)

LUNG 1M: +55.6% · 3M: +22.3% FHTX 1M: -2.6% · 3M: -71.4%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 62

RSI (14): 62.5 · Price: $2.80

FHTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -36.8%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $1.90

Fundamentals Snapshot

Metric LUNG FHTX
Market Cap — —
Forward P/E -3.1 -1.8
Trailing P/E — 22.7
Revenue (TTM) — —
Revenue Growth 0.1% 1.1%
Gross Margin 0.8% -1.1%
Operating Margin -0.3% -0.5%
EPS -1.01 0.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, FHTX is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.